clopidogrel has been researched along with Hypercoagulability in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.63) | 18.2507 |
| 2000's | 19 (50.00) | 29.6817 |
| 2010's | 14 (36.84) | 24.3611 |
| 2020's | 4 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Jiang, W; Wang, J | 1 |
| Brüggemann, R; Gietema, H; Jallah, B; Spaetgens, B; Stehouwer, C; Ten Cate, H | 1 |
| Forleo, GB; Radovanovic, D; Santus, P; Viecca, M | 1 |
| Augustine, TN; Xulu, KR | 1 |
| Adeeb, N; Alturki, A; Enriquez, A; Griessenauer, CJ; Gupta, R; Leadon, M; Moore, JM; Ogilvy, CS; Salem, M; Schmalz, P; Schneider, AM; Thomas, AJ | 1 |
| Hoppe, UC; Jung, C; Lauten, A; Lichtenauer, M; Navarese, EP; Wernly, B | 1 |
| Akhilesh, R; Chow, VTK; Malayer, JR; Maram, P; Pulavendran, S; Rudd, JM; Teluguakula, N; Thomas, PG | 1 |
| Fan, B; Ge, J; Shen, L; Wu, H; Xu, H; Zhao, X | 1 |
| García-Chavez, J; Hernández-Reyes, J; Rosales-Padrón, J; Ruiz-Arguelles, A; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Vargas-Espinosa, J; Velázquez-Sánchez-de-Cima, S; Zamora-Ortiz, G | 1 |
| Dhillon, K; Dovlatova, N; Fox, SC; Glenn, JR; Heptinstall, S; White, AE | 1 |
| Blann, AD; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F | 1 |
| Kioufis, S; Kokkou, E; Mourouzis, K; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stone, PH; Tousoulis, D; Vavuranakis, M; Vlasis, K; Zaromitidou, M | 1 |
| Berger, JS; Smilowitz, NR | 1 |
| Bi, Y; Cao, M; Ding, W; Dong, Z; Guo, L; Jiang, H; Kou, J; Liu, Y; Ma, R; Shi, J; Sun, Y; Tian, Y; Tong, D; Wang, L; Wu, X; Yu, Q; Zhang, Y | 1 |
| Lee, R | 1 |
| Dzialowski, I; Gahn, G; Hermann, A; Koch, R | 1 |
| Healey, JS | 1 |
| Apostolakis, S; Lane, DA; Lip, GY; Shantsila, E | 1 |
| Albanese, A; Di Giuda, D; Di Lazzaro, V; Esposito, G; Maira, G; Puca, A; Tirpakova, B; Tuttolomondo, A | 1 |
| Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A | 1 |
| Ana, G; António, F; Cardona, L; Cruz, FR; Leal, A; Lídia, S; Luísa, B | 1 |
| Johansson, PI; Kofoed, K; Lilleør, NB; Rafiq, S; Steinbrüchel, DA; Stissing, T; Zacho, M | 1 |
| Ball, SA; Dauerman, HL; Desourdy, MA; Furman, MI; Goldberg, RJ | 1 |
| Alfar, H; Bick, RL; Goedecke, C | 1 |
| Tsakiris, DA | 1 |
| Brener, SJ; Lincoff, AM; Moliterno, DJ; Steinhubl, SR; Topol, EJ; Wolski, KE | 1 |
| Hjemdahl, P; Hu, H; Li, N; Perneby, C; Wallén, NH | 1 |
| Antman, EM; Leopold, JA | 1 |
| Herbert, JM; Savi, P | 1 |
| Brosteanu, O; Busch, I; Niebauer, J; Schuler, G; Sick, PB; Thiele, H; Ulrich, M | 1 |
| Bijsterveld, NR; Büller, HR; Di Nisio, M; Levi, M; Meijers, JC; Peters, RJ | 1 |
| Daniel, WG; Eigenthaler, M; Garlichs, CD; Hentschel, B; Hild, E; Kobsar, A; Lohmann, T; Siegemund, A; Spilcke-Liss, E; Stumpf, C; Wallaschofski, H | 1 |
| Hetzer, R; Potapov, EV | 1 |
| Bochsen, L; Nielsen, AB; Steinbrüchel, DA | 1 |
| Lindhoff-Last, E; Linnemann, B; Mani, H; Prochnow, S; Schwonberg, J | 1 |
| Di Gennaro, L; Landolfi, R | 1 |
| Ikeda, Y | 1 |
| Bick, RL; Scott, RG | 1 |
7 review(s) available for clopidogrel and Hypercoagulability
| Article | Year |
|---|---|
Triple therapy: worth the risk?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Humans; Mortality; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Rivaroxaban; Stents; Stroke; Thrombophilia; Ticlopidine | 2018 |
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Humans; Mortality; Numbers Needed To Treat; Observational Studies as Topic; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Stroke; Thiazoles; Thrombophilia; Ticlopidine; Vitamin K | 2015 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Contraindications; Coronary Disease; Disease Susceptibility; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Preanesthetic Medication; Risk Factors; Risk Reduction Behavior; Stress, Physiological; Surgical Procedures, Operative; Thrombophilia; Ticlopidine | 2016 |
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioides difficile; Comorbidity; Cytochrome P-450 CYP2C19; Disease Susceptibility; Drug Interactions; Enterocolitis, Pseudomembranous; Fractures, Spontaneous; Gastrointestinal Hemorrhage; Humans; Hyperparathyroidism, Secondary; Infections; Osteoporosis; Proton Pump Inhibitors; Rheumatic Diseases; Risk; Thrombophilia; Ticlopidine | 2011 |
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Comorbidity; Coronary Restenosis; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Peptide Fragments; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Stents; Thrombophilia; Ticlopidine; Tirofiban; Tyrosine | 2004 |
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Double-Blind Method; Drug Resistance; Fibrinolytic Agents; Forecasting; Humans; Membrane Proteins; Meta-Analysis as Topic; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombophilia; Thrombosis; Ticlopidine | 2005 |
[Antiplatelet therapy].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Collagen; Humans; Immunoglobulin Fab Fragments; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboembolism; Thrombophilia; Ticlopidine | 1999 |
8 trial(s) available for clopidogrel and Hypercoagulability
| Article | Year |
|---|---|
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
Topics: Aged; Aspirin; Betacoronavirus; Clopidogrel; Compassionate Use Trials; Coronavirus Infections; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Hypoxia; Male; Middle Aged; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Proof of Concept Study; SARS-CoV-2; Thrombophilia; Tirofiban | 2020 |
Primary thrombophilia in México X: a prospective study of the treatment of the sticky platelet syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelet Disorders; Child; Clopidogrel; Female; Humans; Male; Mexico; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Syndrome; Thrombophilia; Thrombosis; Ticlopidine; Young Adult | 2015 |
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study pr
Topics: Aspirin; Clinical Protocols; Clopidogrel; Coronary Artery Bypass; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Thrombelastography; Thromboembolism; Thrombophilia; Ticlopidine | 2012 |
Activated clotting times in the setting of eptifibatide use during percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation; Blood Coagulation Tests; Clopidogrel; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombophilia; Ticlopidine | 2002 |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cell Adhesion; Clopidogrel; Cross-Over Studies; Exercise; Humans; Leukocytes; Male; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombophilia; Thromboxane B2; Ticlopidine | 2004 |
Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biocompatible Materials; Carbon; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Coronary Restenosis; Equipment Design; Female; Heparin; Humans; Male; Materials Testing; Middle Aged; Prospective Studies; Recurrence; Stainless Steel; Stents; Thromboembolism; Thrombophilia; Ticlopidine; Time Factors; Treatment Outcome; Venous Thrombosis | 2005 |
Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Anticoagulants; Antithrombin III; Clopidogrel; Heparin; Humans; Myocardial Infarction; Peptide Fragments; Peptide Hydrolases; Platelet Aggregation Inhibitors; Prothrombin; Syndrome; Thrombophilia; Ticlopidine | 2005 |
Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Coronary Artery Bypass, Off-Pump; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombelastography; Thromboembolism; Thrombophilia; Ticlopidine | 2007 |
23 other study(ies) available for clopidogrel and Hypercoagulability
| Article | Year |
|---|---|
A young patient with recurrent myocardial infarction within a half month.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombophilia; Treatment Outcome | 2022 |
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
Topics: Anticoagulants; Cerebral Infarction; Clopidogrel; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Frontal Lobe; Humans; Male; Middle Aged; Nadroparin; Pandemics; Peripheral Arterial Disease; Pneumonia, Viral; Pulmonary Embolism; Recombinant Proteins; Recurrence; Thrombophilia; Tinzaparin; Tissue Plasminogen Activator | 2020 |
Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aspirin; Blood Coagulation; Breast Neoplasms; Cells, Cultured; Clopidogrel; Drug Interactions; Epithelial-Mesenchymal Transition; Female; Humans; Imines; MCF-7 Cells; Platelet Aggregation Inhibitors; Pyridines; Thrombin; Thrombophilia | 2021 |
Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Dose-Response Relationship, Drug; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Retrospective Studies; Risk; Stents; Thromboembolism; Thrombophilia; Ticlopidine; Treatment Outcome | 2018 |
Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.
Topics: Animals; Clopidogrel; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Extracellular Traps; Female; Histones; Influenza A Virus, H1N1 Subtype; Lung; Mice; Neutrophils; Orthomyxoviridae Infections; Oseltamivir; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pneumonia, Viral; Thrombophilia; Virus Replication | 2019 |
Association Between Residual Platelet Reactivity on Clopidogrel Treatment and Severity of Coronary Atherosclerosis: Intrinsic Hypercoagulability as a Mediator.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombelastography; Thrombophilia; Ticlopidine | 2019 |
'VASPFix' for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists.
Topics: Adenosine; Adenosine Diphosphate; Alprostadil; Biomarkers, Pharmacological; Blood Platelets; Bucladesine; Cell Adhesion Molecules; Cells, Cultured; Clopidogrel; Cyclic AMP; Humans; Iloprost; Microfilament Proteins; Phosphoproteins; Phosphorylation; Piperazines; Platelet Aggregation; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Reproducibility of Results; Sensitivity and Specificity; Thiophenes; Thrombophilia; Ticlopidine | 2014 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Female; Genotype; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Smoking; Stents; Thrombophilia; Ticlopidine; Vasodilation | 2015 |
Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation.
Topics: Aged; Aspirin; Blood Cells; Blood Coagulation; Cell-Derived Microparticles; Clopidogrel; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Phosphatidylserines; Platelet Aggregation Inhibitors; Statistics as Topic; Stents; Thrombophilia; Ticlopidine | 2016 |
Ask the doctor. In October 2007, I had three Cypher stents placed in my left anterior descending artery. My doctor told me to take Plavix and aspirin indefinitely. Now I need to have a hernia repaired. My surgeon refuses to operate while I'm taking Plavix
Topics: Aspirin; Clopidogrel; Contraindications; Platelet Aggregation Inhibitors; Stents; Thoracic Surgery; Thrombophilia; Ticlopidine | 2008 |
Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recombinant Proteins; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Ticlopidine; Tissue Plasminogen Activator | 2009 |
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Warfarin | 2009 |
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Vitamin K; Warfarin | 2009 |
Positional brain ischemia with MCA occlusion successfully treated with extra-intracranial bypass.
Topics: Aspirin; Cerebral Revascularization; Clopidogrel; Humans; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Middle Cerebral Artery; Paresis; Parietal Lobe; Platelet Aggregation Inhibitors; Posture; Temporal Arteries; Thrombophilia; Ticlopidine; Tomography, Emission-Computed, Single-Photon | 2010 |
Thrombus formation on a left atrial appendage closure device.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; Heart Diseases; Heparin; Humans; Male; Postoperative Complications; Septal Occluder Device; Thrombophilia; Thrombosis; Ticlopidine; Ultrasonography | 2011 |
Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clinical Laboratory Techniques; Clopidogrel; Dalteparin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retinal Diseases; Retinal Vessels; Thrombophilia; Thrombosis; Ticlopidine; Treatment Outcome | 2002 |
[New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?].
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Thrombophilia; Ticlopidine; Treatment Outcome | 2004 |
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Eptifibatide; Hemorrhage; Length of Stay; Membrane Proteins; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Risk Factors; Stents; Thrombophilia; Ticlopidine | 2005 |
Enhanced platelet activation by prolactin in patients with ischemic stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Leptin; Male; Middle Aged; P-Selectin; Platelet Activation; Prolactin; Retrospective Studies; Risk Factors; Stroke; Thrombophilia; Ticlopidine | 2006 |
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposition to Disease; Genotype; Heart-Assist Devices; Hemorrhagic Disorders; Humans; Incidence; Integrin beta3; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Postoperative Complications; Thromboembolism; Thrombophilia; Ticlopidine | 2006 |
Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Algorithms; Arachidonic Acid; Aspirin; Calibration; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet-Rich Plasma; Sensitivity and Specificity; Thrombophilia; Ticlopidine | 2008 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Hydroxyurea; Janus Kinase 2; Multicenter Studies as Topic; Phlebotomy; Polycythemia Vera; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocythemia, Essential; Thrombophilia; Thrombosis; Ticlopidine; Venous Thrombosis | 2008 |
Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Clopidogrel; Dalteparin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombophilia; Ticlopidine; Treatment Outcome; Varicose Ulcer; Venous Thrombosis | 2001 |